600664.SS
600664.SS
CNE0000009T3
HARBIN PHARMACEUTICAL GROUP CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 15.964.064.819 16.175.856.239
1.3%
Cost of Revenue 11.815.835.068 11.607.227.744
1.8%
Gross Profit 4.148.229.751 4.568.628.495
9.2%
3.417.723.032 3.594.153.262
4.9%
Operating Income 730.506.719 974.475.233
25.0%
Pretax Income 572.738.622 875.006.106
34.5%
Net Income Common Stockholders 361.597.036 628.846.598
42.5%
-- --
--
-- --
--
ende